| Authors: |
Wang L; Formerly of Halozyme Therapeutics, Inc., San Diego, California., Londono LM; Formerly of Halozyme Therapeutics, Inc., San Diego, California., Cowell J; Formerly of Halozyme Therapeutics, Inc., San Diego, California., Saatci O; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, South Carolina., Aras M; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, South Carolina., Ersan PG; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, South Carolina., Serra S; Department of Medical Sciences, University of Torino, Turin, Italy., Pei H; La Jolla Institute for Immunology, La Jolla, California., Clift R; Formerly of Halozyme Therapeutics, Inc., San Diego, California., Zhao Q; Formerly of Halozyme Therapeutics, Inc., San Diego, California., Phan KB; Formerly of Halozyme Therapeutics, Inc., San Diego, California., Huang L; Formerly of Halozyme Therapeutics, Inc., San Diego, California., LaBarre MJ; Halozyme Therapeutics, Inc., San Diego, California., Li X; Formerly of Halozyme Therapeutics, Inc., San Diego, California., Shepard HM; Formerly of Halozyme Therapeutics, Inc., San Diego, California., Deaglio S; Department of Medical Sciences, University of Torino, Turin, Italy., Linden J; La Jolla Institute for Immunology, La Jolla, California., Thanos CD; Formerly of Halozyme Therapeutics, Inc., San Diego, California., Sahin O; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, South Carolina., Cekic C; Formerly of Halozyme Therapeutics, Inc., San Diego, California. caglarcekic@gmail.com. |
